高度多态性恶性疟原虫疫苗候选抗原MSP2在撒哈拉以南非洲的广泛变异
本研究采用巢式PCR和毛细管电泳片段 sizing 对撒哈拉以南非洲34个国家的恶性疟原虫分离株进行msp2基因分型,成功对2761份阳性样本分型,鉴定出412种不同的msp2大小变异。部分变异在地理区域、传播强度和时间点上持续过表达,且核苷酸和氨基酸序列高度多样但无地理聚集。结果表明某些msp2变异广泛流行,可能受结构约束或选择优势影响,有望成为下一代多组分疟疾疫苗的靶点。
要点
- 对34国2761份恶性疟原虫阳性样本进行msp2分型,鉴定出412种大小变异。
- 部分msp2大小变异在地理区域、传播强度和时间点上持续过表达。
- 核苷酸和氨基酸序列高度多样且无地理聚集,广泛变异或受结构约束或选择优势影响。
核心结论
- 某些msp2变异在撒哈拉以南非洲广泛流行,可能受结构约束或选择优势影响,有望成为下一代多组分疟疾疫苗靶点。
研究设计与样本
- 采用巢式PCR和毛细管电泳片段 sizing 对撒哈拉以南非洲34个国家的恶性疟原虫分离株进行msp2基因分型,并用高保真长读长测序探究msp2变异内的序列多样性。
主要发现
- 成功对2761份恶性疟原虫阳性样本进行msp2基因分型,鉴定出412种不同的msp2大小变异。
- 部分msp2大小变异在地理区域、传播强度和时间点上持续过表达,且包含多个独特序列,其中一些在地理和时间上广泛分布。
- 核苷酸和氨基酸序列显示高度多样性,但无地理聚集。
临床怎么用
- 维持特定基因长度和序列的广泛流行msp2变异可作为下一代多组分疟疾疫苗的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A multicomponent vaccine is increasingly recognized as a necessary tool to control and eliminate malaria globally. However, genetic diversity in Plasmodium falciparum poses a significant challenge, particularly for blood-stage antigens associated with protective immunity. Individuals in endemic regions acquire clinical immunity without exposure to all antigenic variants, suggesting that a deeper understanding of antigen diversity could inform more effective vaccine strategies. METHODS: The genetic diversity of the polymorphic gene locus for merozoite surface protein 2 was assessed with nested PCR and capillary electrophoresis fragment sizing in P. falciparum isolates from 34 countries across Sub-Saharan Africa. High fidelity long-read sequencing was used to investigate sequence diversity within msp2 variants. RESULTS: We successfully genotyped msp2 from 2761 P. falciparum-positive samples using capillary electrophoresis, identifying 412 distinct msp2 size variants. Several msp2 size variants were consistently overrepresented across geographical regions, transmission intensities, and time points. These variants comprised multiple unique sequences, of which several were geographically and temporally widespread. Nucleotide and amino acid sequences showed high diversity without geographical clustering. CONCLUSIONS: This study provides a comprehensive assessment of msp2 diversity across Sub-Saharan Africa. The widespread prevalence of certain variants of this highly polymorphic antigen suggests possible structural constraints or selective advantages for the parasite. Maintenance of specific gene lengths and sequences across diverse settings highlights their potential as targets for next-generation, multicomponent malaria vaccines.
引用
- Zerebinski J, Broumou I, Kimenyi KM, et al. Widespread variants of the highly polymorphic Plasmodium falciparum vaccine candidate antigen MSP2 across Sub-Saharan Africa. J Infect Dis. 2026. PMID: 42484022. doi:10.1093/infdis/jiag377
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。